Your session is about to expire
← Back to Search
Noninvasive Brain Stimulation
Active tDCS for Associative Memory
N/A
Waitlist Available
Led By Sven Vanneste, PhD
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up memory performance changes will be assessed in two different visits. first assessment (baseline) on visit 1 (learning), then one-week after during visit 2 (memory)
Awards & highlights
Study Summary
This trial will test whether a non-invasive brain stimulation technique can help healthy people learn and remember better.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ memory performance changes will be assessed in two different visits. first assessment (baseline) on visit 1 (learning), then one-week after during visit 2 (memory)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~memory performance changes will be assessed in two different visits. first assessment (baseline) on visit 1 (learning), then one-week after during visit 2 (memory)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
A Computerized Verbal Paired-associate Memory Task Will be Used to Assess Memory Performance.
Side effects data
From 2012 Phase 3 trial • 60 Patients • NCT0164923210%
headache
10%
headedness / dizziness
7%
fatigue or nausea
100%
80%
60%
40%
20%
0%
Study treatment Arm
Active tDCS
Controls
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active tDCSExperimental Treatment1 Intervention
active HD-tDCS will be administered
Group II: Sham tDCSPlacebo Group1 Intervention
sham HD-tDCS will be administered
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active tDCS
2012
Completed Phase 3
~1150
Find a Location
Who is running the clinical trial?
The University of Texas at DallasLead Sponsor
58 Previous Clinical Trials
106,245 Total Patients Enrolled
Sven Vanneste, PhDPrincipal InvestigatorThe University of Texas at Dallas
6 Previous Clinical Trials
210 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger